Diabetic Neuropathies Clinical Trial
Official title:
Effects of Foot Muscle Strengthening in Daily Activity, Biomechanics and Functionality of Foot and Ankle in Diabetic Polyneuropathy Patients: a Randomized Controlled Trial
| NCT number | NCT02790931 |
| Other study ID # | LaBiMPH |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | August 2016 |
| Est. completion date | December 2020 |
| Verified date | April 2024 |
| Source | University of Sao Paulo General Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The main objective of this trial is to investigate the effects of foot muscle strengthening in daily activity of patients with diabetic neuropathy.
| Status | Completed |
| Enrollment | 78 |
| Est. completion date | December 2020 |
| Est. primary completion date | December 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 75 Years |
| Eligibility | Inclusion Criteria: - Diabetes mellitus type 1 or 2 - Moderate or severe polyneuropathy confirmed with the fuzzy software - Ability to walk independently in the laboratory - Accessibility to electronic devices - Loss of at least 4 degrees of ankle range of motion - Loss of at least 1 degree of force in the clinical scale of the plantar interosseous or lumbrical muscles Exclusion Criteria: - Ulceration not healed for at least 6 months - Hallux amputation or total amputation of the foot - Receiving any physiotherapy intervention or offloading devices - Neurological or orthopedic impairments - Major vascular complications - Severe retinopathy |
| Country | Name | City | State |
|---|---|---|---|
| Brazil | Universidade de São Paulo | São Paulo |
| Lead Sponsor | Collaborator |
|---|---|
| University of Sao Paulo General Hospital |
Brazil,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Daily Physical Activity | Calculate the number of steps per week | 12 weeks | |
| Primary | Self Selected Gait Speed | self selected gait speed shod walking velocity in a walkway | 12 weeks | |
| Primary | Fast Gait Speed | Fast gait speed shod walking velocity in a walkway | 12 weeks | |
| Secondary | Risk Classification of Plantar Ulceration | Score of the classification of the plantar ulcer risk (IWG diabetic foot) | 12 weeks | |
| Secondary | Foot Health and Functionality | Score of the Foot Health Status questionnaire - BRAZIL | 12 weeks | |
| Secondary | Foot Strength | Hallux and lesser toes force measured by a pressure plate | 12 weeks | |
| Secondary | Foot and Ankle Kinematics During Gait | Foot joints and plantar arch motion, ankle range of motion, and maximum ankle extension and flexion during gait | baseline, 12 weeks | |
| Secondary | Ankle and Knee Joint Moments and Power During Gait | Peak joint moment and eccentric and concentric power by inverse dynamic calculations | baseline, 12 weeks | |
| Secondary | Plantar Ulcers | New cases of foot plantar ulcers | 12 months | |
| Secondary | Tactile Sensitivity | Evaluation of the tactile sensitivity of four plantar areas with 10g monofilament | 12 weeks | |
| Secondary | Vibration Sensitivity | Evaluation of the vibration sensitivity with tuning fork | 12 weeks | |
| Secondary | Neuropathy Symptoms | Score of the Michigan Neuropathy Screening Instrument questionnaire Michigan Neuropathy Screening Instrument (MNSI) | 12 weeks | |
| Secondary | Range of Motion | Manual goniometry of the range of motion of flexion and extension of the metatarsophalangeal joint of the hallux and ankle. | 12 weeks | |
| Secondary | EQ-5D Score | EQ-5D score of the quality of life of the patient | 12 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05683106 -
Effects of Customized Silicone Digital Orthoses in People With Diabetic Neuropathy
|
N/A | |
| Withdrawn |
NCT04106050 -
Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy
|
Phase 1 | |
| Completed |
NCT04088929 -
The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy
|
Phase 2 | |
| Completed |
NCT01939366 -
Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
|
Phase 2 | |
| Withdrawn |
NCT00815932 -
The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic Neuropathy
|
N/A | |
| Completed |
NCT01926522 -
Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic Patients
|
N/A | |
| Not yet recruiting |
NCT01180608 -
Functional Imaging of the Therapeutic Effect of Pregabalin in Treatment for Neuropathic Pain
|
N/A | |
| Completed |
NCT00380913 -
Evaluation of the Efficacy of Cesametâ„¢ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy
|
Phase 4 | |
| Completed |
NCT00760955 -
Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy
|
Phase 2 | |
| Terminated |
NCT00756041 -
Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy
|
Phase 2 | |
| Completed |
NCT05255497 -
The Effect of Sensorial Biodex Balance Balance System Exercises in Diabetic Neuropathy
|
N/A | |
| Completed |
NCT06061237 -
Effects of Aerobic Thai Dance in Patient With Diabetic Peripheral Neuropathy
|
N/A | |
| Terminated |
NCT02915263 -
The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
|
Phase 2 | |
| Enrolling by invitation |
NCT05043636 -
Diabetic Neuropathy Screening Study 1.1 + Substudy 1.2-1.3-1.4
|
||
| Completed |
NCT06373809 -
Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy
|
Early Phase 1 | |
| Completed |
NCT05968131 -
Comparative Effects of Proprioceptive Training and Routine Physical Therapy on Diabetic Peripheral Neuropathy
|
N/A | |
| Completed |
NCT00282685 -
Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy
|
Phase 1 | |
| Completed |
NCT00135109 -
Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy
|
Phase 3 | |
| Completed |
NCT06292962 -
Evaluating the Impact of Vagus Nerve Stimulation on Diabetic Peripheral Neuropathic Pain
|
N/A | |
| Completed |
NCT05058807 -
Effects of Whole Body Vibration in Diabetic Peripheral Neuropathy .
|
N/A |